Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus, originated from the Wuhan region of Hubei province in China late in 2019.
AffinityImmuno has been involved in developing research tools to accelerate the fight against SARS-CoV-2 since February 2020 when we performed our first immunizations to generate research antibodies.
COVID-19 Spike Protein Antibodies
AffinityImmuno was among the first suppliers of antibodies to SARS-CoV-2 by immunizing our lay hen flock beginning in February 2020 to generate polyclonal antibodies to:
Affinity purified and antibody pairs
In addition to bulk polyclonal antibodies, we have the following affinity purified and antibody pairs:
5 Kits – COVID-19 Spike Capture and Detection (HRP conjugate) ELISA pair with calibrator